Semaglutide, a compounded GLP-1, is a red liquid inside a peptide vial, with the bottle set in front of a dark grey background.
Tirzepatide, a compounded GLP-1, shown as a red liquid inside a peptide vial, with the bottle set in front of a dark grey background.
A woman bunches her skin together in search of a weight management solution.
Semaglutide, a compounded GLP-1, is a red liquid inside a peptide vial, with the bottle set in front of a dark grey background.
Tirzepatide, a compounded GLP-1, shown as a red liquid inside a peptide vial, with the bottle set in front of a dark grey background.
A woman bunches her skin together in search of a weight management solution.
Shed & Thrive

Compounded GLP-1

Lose weight & control blood sugar

Compounded GLP-1 activates GIP and GLP-1 receptors to help you feel fuller longer, support healthy insulin sensitivity, and drive sustainable weight management. Available various formats, RegenMD offers Semaglutide or Tirzepatide; both GLP-1s containing FDA-approved active ingredients used in leading prescription weight management therapies.

RegenMD prescribes compounded GLP-1 therapy with personalized dosing tailored to your body and goals. Best results are achieved alongside a healthy diet and consistent exercise.

Variants
Compounded GLP-1
  • Overview
  • Specifications
  • Has been shown to help lose weight in overweight patients
  • FDA-approved to help reduce blood sugar levels in patients with type 2 diabetes
  • Can improve insulin resistance and even symptoms of PCOS
  • Should be used along with diet modification and exercise
  • GLP-1 (either Tirzepatide or Semaglutide)
  • Vitamin B12

GLP-1 dosages are unique to each patient and depend on type of GLP-1. Please refer to your provider for dosing regimen.

Compounded GLP-1s are administered as a subcutaneous (SubQ) injection, with a 30G/31G syringe at the prescribed dosage.

Injection Tutorial

How Compounded GLP-1 Works

Compounded GLP-1 therapy uses two of the most clinically studied active ingredients in modern weight management medicine: semaglutide and tirzepatide. Both belong to a class of medications that mimic natural gut hormones to regulate appetite, blood sugar, and metabolism. They work through slightly different mechanisms, which is why patient responses and outcomes vary between the two.

Semaglutide is a GLP-1 receptor agonist that signals the brain to reduce hunger, slows gastric emptying so you feel fuller longer, and improves insulin sensitivity to support steadier blood sugar throughout the day. By reducing caloric intake naturally without the constant battle against appetite, semaglutide supports a sustainable calorie deficit and consistent fat loss over time.

Tirzepatide operates as a dual agonist, activating both GLP-1 and GIP (glucose-dependent insulinotropic polypeptide) receptors simultaneously. This dual mechanism amplifies appetite suppression and produces stronger metabolic effects than single-receptor agonists in many patients. Clinical trial data has consistently shown higher average weight loss with tirzepatide compared to semaglutide, though individual responses vary based on health history, metabolism, and adherence.

Vitamin B12, included in RegenMD's compounded GLP-1 formula, supports energy metabolism and neurological function, helping offset fatigue some patients experience during caloric restriction and adding nutritional support to the overall protocol.

Compounded semaglutide and tirzepatide are prepared by a licensed 503A pharmacy using FDA-approved active ingredients. Compounding allows for flexible, provider-adjusted dosing—a key advantage when titrating up during the first several weeks to minimize side effects and optimize response.

At RegenMD, GLP-1 therapy is prescribed as part of a broader personalized wellness plan. Patients who combine treatment with nutritional guidance and regular movement consistently see the strongest long-term outcomes. Your provider monitors progress throughout the program and adjusts dosing as needed at each check-in.

What This Means For You

  • Reduced appetite and hunger signals
  • Sustained fat loss through improved metabolism and insulin sensitivity
  • Steadier blood sugar and energy levels
  • Longer-lasting fullness after smaller meals
  • Flexible, personalized dosing adjusted by a licensed provider
  • Ongoing medical supervision throughout the program
  • Available nationwide via telehealth

Frequently Asked Questions

Semaglutide activates GLP-1 receptors only, while tirzepatide activates both GLP-1 and GIP receptors simultaneously. Clinical trials have shown higher average weight loss with tirzepatide, though individual responses vary based on health history, metabolism, and lifestyle. Your RegenMD provider will determine which option fits your goals during your evaluation.

Caloric restriction during GLP-1 therapy reduces overall food intake, which can lower B12 absorption over time; particularly in patients who already have marginal B12 levels. B12 supports energy metabolism, neurological function, and red blood cell production; deficiencies can produce fatigue and brain fog that patients may incorrectly attribute to the GLP-1 protocol itself. Including B12 directly in the compounded formula addresses this proactively without requiring a separate supplement.

GLP-1 receptor agonists slow gastric emptying and alter gut hormone signaling; introducing a full therapeutic dose immediately produces a strong and often uncomfortable gastrointestinal response in most patients.

Titrating up from a lower starting dose over several weeks allows the GI tract to adapt progressively. It also allows your provider to identify the minimum effective dose for your specific response; some patients achieve optimal results below the standard therapeutic ceiling, which titration makes visible in a way that starting high does not.

GLP-1 receptor agonists work by actively modifying hormonal signaling around appetite, satiety, and insulin response; these effects are present only while the compound is in the system. Clinical data consistently shows that outcomes can reverse following discontinuation without concurrent lifestyle changes.

Patients who use the protocol to establish new eating patterns and metabolic habits during treatment tend to sustain results more successfully than those who rely on the medication alone. Discontinuation strategy is something your RegenMD provider will assess based on your individual response and long-term goals rather than applying a fixed endpoint to every patient.

GLP-1 receptor agonists enhance insulin secretion in response to meals and reduce glucagon release; supporting the body's ability to process glucose more efficiently and reducing the blood sugar spikes that drive fat storage and energy crashes after eating.

For patients with underlying insulin resistance; a common factor in weight gain particularly around the abdomen; addressing this mechanism produces metabolic effects beyond appetite suppression alone. Many patients report more stable energy throughout the day and reduced cravings for high-sugar foods as secondary benefits; both of which directly support the dietary adherence that determines long-term outcomes.

Getting Started Is Easy

Step 1: Consultation

A consultation to explore your goals, answer questions, and outline your wellness plan.

Step 2: Evaluation

Meet with a provider for a personalized evaluation and tailored peptide treatment plan.

Step 3: Activation

Finalize your order, receive treatment details, and begin your wellness journey.

Book a Consulation